Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

A Study to Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients

NCT00911859

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Boston, Massachusetts, United States
  • Chapel Hill, North Carolina, United States
  • Philadelphia, Pennsylvania, United States
  • Houston, Texas, United States
View all 37 locations
View Trial Details
Completed

MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning

NCT00564200

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • H. Clinic I Provincial Barcelona, Spain
  • H. de la Santa Creu I Sant Pau Barcelona, Spain
  • Instituto Catalán de Oncología Barcelona, Spain
  • H. de Jerez Jerez de la Frontera, Spain
View Trial Details
Completed

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

NCT00891137

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +59 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
View Trial Details

Related conditions